Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
167.80
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
53
54
Next >
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
November 20, 2023
Via
Benzinga
7 High-Yield Blue Chips Suitable for Any Retiree
November 17, 2023
Here are seven high-yield blue-chip stocks to help you meet your retirement goals no matter where you are on your investment journey.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.
Via
Benzinga
AbbVie Unusual Options Activity
November 14, 2023
Via
Benzinga
AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell?
November 16, 2023
Both companies' share prices have slipped recently.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
7 Dividend Stocks Every Investor Should Own to Survive a Market Crash
November 14, 2023
When the going gets tough, the tough buy dividend stocks for a market crash because the income they generate softens the downturn's blow.
Via
InvestorPlace
2 High-Yield Dividend Stocks You Can Buy Now and Hold for a Decade
November 14, 2023
These stocks could be great investments to bump up your passive income stream.
Via
The Motley Fool
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing
November 14, 2023
You'll be happy to own these top companies in any market environment.
Via
The Motley Fool
AbbVie Unusual Options Activity
November 09, 2023
Via
Benzinga
Looking Into AbbVie's Recent Short Interest
November 07, 2023
Via
Benzinga
$1000 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
November 06, 2023
Via
Benzinga
3 Growth Stocks to Buy Right Now Without Any Hesitation
November 11, 2023
Investors shouldn't have to deliberate for too long about these great stocks.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
Via
Benzinga
AbbVie's $21 Billion Drug Humira Is on the Decline. Should You Still Buy This Dividend Stock?
November 10, 2023
AbbVie is committed to rewarding shareholders, even during tough times.
Via
The Motley Fool
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
November 09, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
3 Dividend Stocks That Are Perfect for Beginning Investors
November 07, 2023
For new market participants, these dividend stocks for beginners should steer your portfolio in the right direction.
Via
InvestorPlace
Check Out What Whales Are Doing With ABBV
November 03, 2023
Via
Benzinga
Is AbbVie Stock a Buy Now?
November 03, 2023
It just had a brutal quarter, and it might have a couple more on the way.
Via
The Motley Fool
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
The company's recently FDA-approved gene therapy is struggling to gain traction.
Via
Investor's Business Daily
Why Former Highflier MoonLake Plummeted 29% After A Recent Run
November 06, 2023
The company tested its drug over 12 weeks in 207 patients. All but one regimen led to statistically significant improvements.
Via
Investor's Business Daily
3 Spectacular High-Yield Dividend Stocks to Buy in November
November 05, 2023
Income investors should find plenty to like with these stocks.
Via
The Motley Fool
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
November 04, 2023
Dividend stocks can cushion your portfolio in times of market trouble.
Via
The Motley Fool
Top 5 Dividend Stocks In My $4 Million Portfolio (With Growth Potential In 2024)
November 02, 2023
In this blog post, we’re going to explore the world of dividend stocks and I’ll share my top five picks.
Via
Talk Markets
Meet the Next Trillion-Dollar Companies: Our Top 3 Picks
November 02, 2023
Of the current five trillion-dollar companies, several more are within shouting distance. Here are our top three picks to get there.
Via
InvestorPlace
EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'
November 02, 2023
A new ETF offers investors exposure to companies with long streaks of raising their dividends.
Via
Benzinga
Topics
ETFs
3 Dividend Stocks That Are Investor Safe Havens
November 02, 2023
If there is such a thing as safe dividend stocks, these three should be at the top of your list to consider.
Via
InvestorPlace
3 Dividend Stocks That Can Power Your Portfolio for Decades
November 02, 2023
From healthcare to home repair to tech, these stocks can help diversify your holdings.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.